The activity reflects routine option exercise and modest monetization by executives, not a coordinated exit. Traders should monitor for any follow-up filings or news around earnings or pipeline updates, but this cluster alone does not signal material concern or optimism.
Price Chart
Executive Summary
Over the past seven days, key insiders at United Therapeutics, including CEO Martine Rothblatt and CFO James Edgemond, exercised stock options and conducted open-market sales totaling approximately $2.3 million in proceeds. The majority of transactions involved derivative exercises, with over $5.7 million in non-cash option exercises, while actual open-market sales amounted to $1.07 million.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt exercised options for 38,000 shares at $146.03 (total value: $5.57M) and sold 919 shares for $479,625 in open-market transactions.
- CFO James Edgemond exercised options for 10,000 shares at $135.42 (value: $1.35M) and sold 200 shares for $103,657.
- EVP Paul Mahon exercised options for 8,300 shares at $146.03 (value: $1.21M) and sold 753 shares for $397,184.
- Director Judy Olian sold 200 shares for $106,000.
- Total open-market sales: ~$1.07 million across four insiders.
- Total derivative exercises: ~$8.1M in value, mostly non-cash events (codes M and A).
- Total value of actual share sales: ~0.0046% of $23.3B market cap — immaterial in scale.
Financial Impact
$1.07 million in open-market insider selling over 7 days, alongside $8.1 million in option exercises. No dilution or direct financial impact from non-cash transactions.
Risk Factors
- Perception risk if investors misinterpret option exercises and sales as negative sentiment, despite being routine for executives with vested options.
- Concentration risk in CEO transactions — Martine Rothblatt accounts for the vast majority of activity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (19 trades, 7d window) | cluster-UTHR-1774470698276 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $571.38 (+14.20%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $571.38 (+14.94%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $571.38 (+13.40%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $571.38 (+12.74%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $571.38 (+17.18%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $571.38 (+17.05%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $571.38 (+10.85%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $571.38 (+8.23%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access